AUDENTES THERAPEUTICS INC - COM (BOLD)

CUSIP: 05070R104

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COM
Total 13F shares
43,024,345
Share change
-2,221,216
Total reported value
$2,574,456,027
Put/Call ratio
799%
Price per share
$59.84
Number of holders
185
Value change
+$256,265,768
Number of buys
119
Number of sells
80

Quarterly Holders Quick Answers

What is CUSIP 05070R104?
CUSIP 05070R104 identifies BOLD - AUDENTES THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AUDENTES THERAPEUTICS INC - COM (BOLD) as of Q4 2019

As of 31 Dec 2019, AUDENTES THERAPEUTICS INC - COM (BOLD) was held by 185 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,024,345 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Magnetar Financial LLC, ALPINE ASSOCIATES MANAGEMENT INC., CNH PARTNERS LLC, STATE STREET CORP, Partner Fund Management, L.P., FARALLON CAPITAL MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P., and Casdin Capital, LLC. This page lists 185 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.